iPSC-Derived Pulmonary & Hepatic Organoid Models for NAMs
Key takeaways:
- Reproducible hPSC-derived models for disease modeling, toxicity & mechanistic studies
- Featuring HepatiCult™ and STEMdiff™ AT2 Alveolosphere Kit
This presentation does not represent an endorsement from or support of the ISSCR.
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Related Multimedia
-
Drug Discovery with In Vitro NAMs: Expert Roundtable
Publish Date: June 15, 2026 -
ISSCR Consortium: Stem Cell-Based Models in Drug Discovery
Publish Date: June 15, 2026 -
NAMs in Regulatory Toxicology: Challenges & Considerations
Publish Date: June 15, 2026
Explore Our Products
-
Serum-free medium for efficient and reproducible generation of lung progenitor cells from human ES and iPS cells -
STEMdiff™ Hepatic Organoid Media
Serum-free cell culture media for the growth and differentiation of hepatic organoids from hPSC-derived hepatocyte-like cells -
STEMdiff™ Definitive Endoderm Kit
Defined animal component-free medium for the differentiation of human ESCs and iPSCs to definitive endoderm -
Human iPSC-Derived Hepatic Organoids
Frozen human hepatocyte-like cell-derived organoids generated from human induced pluripotent stem cell lines
